Form 4: Xeris Biopharma Director James Brady Acquires 100,000 Shares Through Restricted Stock Unit Award

Director James Aloysius Brady acquired 100,000 shares of Xeris Biopharma Holdings, Inc. through a restricted stock unit award.

Summary

• On March 28, 2025, James Aloysius Brady, a director of Xeris Biopharma Holdings, Inc., acquired 100,000 shares of common stock.
• The acquisition was made through a restricted stock unit (RSU) award under the company's 2018 Stock Option and Incentive Plan.
• Each RSU represents a contingent right to receive one share of Xeris Biopharma's common stock.
• The shares vest in equal annual installments over three years, contingent upon continued service on the company's Board of Directors.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard transaction by a company director, with no explicit positive or negative implications.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future prospects.
• The vesting schedule incentivizes continued service and commitment from the director.

Risks

• The value of the acquired shares is subject to the market performance of Xeris Biopharma Holdings, Inc.
• The vesting of the shares is contingent upon continued service on the Board of Directors, creating a potential risk if the director leaves the company.

Future Outlook

The acquired shares will vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be a signal of management's confidence in the company's prospects.

Stakeholder Impact

• The acquisition of shares by a director may positively influence shareholder sentiment.
• The vesting schedule incentivizes the director to remain committed to the company's success, benefiting all stakeholders.

Key Dates

Keywords

Xeris Biopharma, Director, James Brady, Stock Acquisition, Restricted Stock Units, Form 4, Beneficial Ownership